PlacidWay and Cell Grand Clinic Announce Partnership to Connect Global Patients with Japan's Regenerative Medicine

International patients gain a clearer route to physician-led cellular care as Japan’s regulated sector draws wider global interest.

DENVER, CO, UNITED STATES, August 11, 2026 /EINPresswire.com/ -- PlacidWay, an industry-leading international medical tourism and healthcare marketplace, has announced a landmark partnership with Cell Grand Clinic, a premier regenerative medicine facility in Shinsaibashi, Osaka. This collaboration aims to provide international patients with seamless access to 13 government-approved, advanced cellular therapies, cementing Japan’s position as a foremost destination for safe, regulated, and scientifically rigorous stem cell treatments.

Japan Stem Cell Therapy has rapidly emerged as the global epicenter of regenerative medicine, driven by a progressive legal framework that includes a dedicated pathway for cell-based treatment plans and expedited approvals for regenerative medical products. The Japanese Ministry of Health, Labour and Welfare enforces stringent safety and quality protocols, offering patients unprecedented transparency regarding cell sourcing, processing, testing, and physician oversight. This environment allows certified clinics to administer breakthrough therapies often unavailable or heavily restricted in other regions.

The PlacidWay and Cell Grand Clinic initiative strategically targets patients in the United States, China, South Korea, Vietnam, the Philippines, Indonesia, Singapore, and other Asia-Pacific markets. With the Centers for Disease Control and Prevention reporting millions of U.S. residents traveling abroad for care annually, this partnership addresses the growing need for reliable, high-quality, and transparent regenerative healthcare across borders.

Cell Grand Clinic stands at the forefront of this medical revolution under the leadership of Dr. Yuichi Wakabayashi, M.D., Ph.D. — who holds a Certificate in Stem Cell Medicine from Harvard Medical School and the ISSCR, is board-certified by the American Board of Regenerative Medicine, and has been named a Wall Street Journal “Next Era Leader.” A former NIH researcher and author of seven peer-reviewed papers indexed in PubMed, Dr. Wakabayashi has personally performed over 3,000 stem cell treatments. The clinic pioneers a proprietary “Grand Stem Cells” protocol, culturing cells exclusively for each individual patient. This bespoke process ensures ISCT-verified identity, maximum youthfulness (Passage ≤ 3), and over 95% cellular viability prior to administration, distinguishing it from facilities relying on mass-produced or stockpiled cells.

Through this partnership, global patients can access Cell Grand Clinic’s extensive expertise, which includes:

● Metabolic & Neurological Care: Advanced protocols for Type 2 Diabetes Management, Dementia & Cognitive Support, and Post-Stroke Recovery Support.
● Orthopedic & Physical Restoration: Non-surgical Knee Osteoarthritis Repair and Chronic Pain Management using autologous adipose-derived stem cells — an area in which the clinic has published a peer-reviewed one-year outcome report in the medical journal Cureus (2026).
● Preventative & Systemic Health: Immune Support through NK Cell Immunotherapy, and holistic Menopause Symptom Relief.
● Aesthetic & Vitality Revitalization: Skin Rejuvenation utilizing dual-cell Fibroblast therapy, alongside regenerative treatments for Androgenetic Alopecia (AGA) and Erectile Dysfunction (ED).

“Our mission is to extend the healthy lifespan of our patients by harnessing their body’s innate regenerative power,” said Dr. Yuichi Wakabayashi, Director of Cell Grand Clinic. “By maintaining uncompromising standards for our ‘Grand Stem Cells,’ we deliver therapies that target the root causes of chronic and age-related conditions without the systemic burden of conventional surgery. Partnering with PlacidWay allows us to bridge the geographical gap, offering international patients a transparent, science-driven pathway to reclaim their health and vitality in Japan.”

Reflecting this commitment to transparency, Dr. Wakabayashi’s one-year outcome report on adipose-derived stem cell therapy for knee osteoarthritis was published in the peer-reviewed medical journal Cureus in 2026 (DOI: 10.7759/cureus.113830), adding independently verifiable clinical documentation to the clinic’s growing body of research.

“Japan’s momentum in regenerative medicine is undeniable, establishing the definitive gold standard for safety, regulation, and innovation,” said Pramod Goel, CEO and Founder of PlacidWay. “Cell Grand Clinic’s dedication to uncompromising cellular quality and their impressive portfolio of 13 Ministry of Health-certified therapies make them a truly unique provider in the global industry. This partnership directly supports our mission to empower patients worldwide with access to transformative, world-class treatments that profoundly improve their quality of life, eliminating the struggle to compare treatment claims across borders.”

Together, PlacidWay and Cell Grand Clinic are streamlining the medical travel experience, offering end-to-end support for international patients seeking to benefit from the highest echelon of Japanese medical innovation.

About Cell Grand Clinic

Located in the heart of Shinsaibashi, Osaka, Japan, Cell Grand Clinic is a premier, government-certified facility specializing in advanced regenerative medicine. Under the direction of Dr. Yuichi Wakabayashi, M.D., Ph.D., the clinic offers personalized stem cell, fibroblast, and NK cell therapies designed to address chronic disease, joint degeneration, and systemic aging with uncompromising quality control. Learn more at https://www.placidway.com/profile/325561/Cell-Grand-Clinic-Best-Stem-Cell-Clinic-in-Japan.

About PlacidWay

Founded in 2007 and headquartered in Denver, PlacidWay Medical Tourism is a healthcare discovery and patient-engagement Platform as a Service connecting global patients directly with participating providers. Its multilingual ecosystem supports provider education, comparison, inquiry management and cross-border communication at https://www.placidway.com.

Pramod Goel
PlacidWay Medical Tourism
+1 888-296-6664
info@placidway.com
Visit us on social media:
LinkedIn
Bluesky
Instagram
Facebook
YouTube
TikTok
X